Monitoring antimicrobial use and resistance: Comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci

Emerging Infectious Diseases

Volumn 8, Issue 7, 2002, Pages 702-707

  Fridkin, Scott K ^a,c   Lawton, Rachel ^a   Edwards, Jonathan R ^a   Tenover, Fred C ^a   McGowan Jr , John E ^b   Gaynes, Robert P ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG MONITORING; DRUG USE; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; UNITED STATES;

EID: 0036310962     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0807.010465     Document Type: Article

References (24)

1. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: The complexity of the problem
2. Preventing the emergence of antimicrobial resistance: A call for action by clinicians, public health officials, and patients
3. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
4. Controlling use of antimicrobial agents
5. The potential for clinical guidelines to impact appropriate antimicrobial agent use
6. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals
7. Recommendations for preventing the spread of vancomycin resistance
8. Practices to improve antimicrobial use at 47 U.S. hospitals: The status of the 1997 SHEA/IDSA position paper recommendations
9. Benchmarking and quality improvement: The Harvard Emergency Department Quality Study
10. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery
11. Risk-adjusted infection rates in surgery: A model for outcome measurement in hospitals developing new quality improvement programs
12. Monitoring hospital-acquired infections to promote patient safety-United States, 1990-1999
13. Surveillance of antimicrobial use and antimicrobial resistance in U.S. Hospitals: Project ICARE Phase 2
14. CDC definitions for nosocomial infections, 1988
15. National nosocomial infections surveillance (NNIS): Description of surveillance methods
16. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: A survey of Project ICARE laboratories
17. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997
18. Determinants of vancomycin use in adult intensive care units at U.S. hospitals
19. Recommendations for preventing the spread of vancomycin resistance recommendations of the hospital infection control practices advisory committee (HICPAC)
20. The framework of health care reform
21. The outcomes movement-will it get us where we want to go?
22. Opinion leaders versus audit and feedback to implement practice guidelines: Delivery after previous cesarean section
23. Changing surgical antimicrobial prophlylaxis practices through education targeted at senior department leaders